At the time of writing, Icecure Medical Ltd [ICCM] stock is trading at $1.37, up 5.38%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ICCM shares have gain 22.32% over the last week, with a monthly amount glided 67.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Icecure Medical Ltd fluctuated between $0.48 and $1.57. Currently, Wall Street analysts expect the stock to reach $2.5 within the next 12 months. Icecure Medical Ltd [NASDAQ: ICCM] shares were valued at $1.37 at the most recent close of the market. An investor can expect a potential return of 82.48% based on the average ICCM price forecast.
Analyzing the ICCM fundamentals
According to Icecure Medical Ltd [NASDAQ:ICCM], the company’s sales were 3.67M for trailing twelve months, which represents an 102.45% jump. Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -3.95%, Pretax Profit Margin comes in at -3.74%, and Net Profit Margin reading is -3.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.91, Equity is -1.26 and Total Capital is -1.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3200 points at the first support level, and at 1.2700 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4300, and for the 2nd resistance point, it is at 1.4900.
Ratios To Look Out For
It is important to note that Icecure Medical Ltd [NASDAQ:ICCM] has a current ratio of 2.67. Further, the Quick Ratio stands at 2.27, while the Cash Ratio is 2.14. Considering the valuation of this stock, the price to sales ratio is 21.61, the price to book ratio is 7.46.
